Amid a roller-coaster end to 2024 for the stock market, dividend-paying stocks continued to lag the broader market. However, ...

Bristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes and sells ...

Schwab U.S. Dividend Equity ETF is a clear buy with a look at its top 10 holdings. Click here to why I rate SCHD a Buy.

This double-digit growth in new drug sales showcases the company's ability to successfully commercialize cutting-edge ...

Legacy Private Trust Co. lifted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.3% during the 4th quarter, ...

International Assets Investment Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 98.4% ...

Highlights,Bristol-Myers Squibb beats quarterly earnings estimates.,Dividend increased, maintaining strong returns.,Insider ...

The stock market’s bullish sentiment for the magnificent seven stocks may weaken anytime. When that happens is not ...

Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...

We recently compiled a list of the Early Retirement Portfolio: 10 Stocks to Live Off Dividends. In this article, we are going ...

These seven blue-chip dividend stocks provide investors a steady stream of passive income and offer promising total return.

Explore the recent performance of the SCHD ETF's performance in 2024 and what to expect in the next few months and why it may ...